KR100200324B1 - Recombinant baculovirus containing vp2 gene of canine parvovirus, a method for producing recombinant vp2 protein, and a vaccine containing recombinant vp2 protein - Google Patents

Recombinant baculovirus containing vp2 gene of canine parvovirus, a method for producing recombinant vp2 protein, and a vaccine containing recombinant vp2 protein Download PDF

Info

Publication number
KR100200324B1
KR100200324B1 KR1019960065807A KR19960065807A KR100200324B1 KR 100200324 B1 KR100200324 B1 KR 100200324B1 KR 1019960065807 A KR1019960065807 A KR 1019960065807A KR 19960065807 A KR19960065807 A KR 19960065807A KR 100200324 B1 KR100200324 B1 KR 100200324B1
Authority
KR
South Korea
Prior art keywords
recombinant
protein
gene
canine parvovirus
producing
Prior art date
Application number
KR1019960065807A
Other languages
Korean (ko)
Other versions
KR19980047324A (en
Inventor
Jong-Hyeon Park
Jae-Yeong Song
Jong-Oh Lee
Bang-Hun Hyun
Dong-Jun An
Soo-Jwan An
Byung-Han Kim
Young-Won Kang
Jae-Jin Lee
Original Assignee
Rep Korea Nat Vet & Quarantine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rep Korea Nat Vet & Quarantine filed Critical Rep Korea Nat Vet & Quarantine
Priority to KR1019960065807A priority Critical patent/KR100200324B1/en
Publication of KR19980047324A publication Critical patent/KR19980047324A/en
Application granted granted Critical
Publication of KR100200324B1 publication Critical patent/KR100200324B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14041—Use of virus, viral particle or viral elements as a vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14051—Methods of production or purification of viral material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
KR1019960065807A 1996-12-14 1996-12-14 Recombinant baculovirus containing vp2 gene of canine parvovirus, a method for producing recombinant vp2 protein, and a vaccine containing recombinant vp2 protein KR100200324B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019960065807A KR100200324B1 (en) 1996-12-14 1996-12-14 Recombinant baculovirus containing vp2 gene of canine parvovirus, a method for producing recombinant vp2 protein, and a vaccine containing recombinant vp2 protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019960065807A KR100200324B1 (en) 1996-12-14 1996-12-14 Recombinant baculovirus containing vp2 gene of canine parvovirus, a method for producing recombinant vp2 protein, and a vaccine containing recombinant vp2 protein

Publications (2)

Publication Number Publication Date
KR19980047324A KR19980047324A (en) 1998-09-15
KR100200324B1 true KR100200324B1 (en) 1999-06-15

Family

ID=19487896

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019960065807A KR100200324B1 (en) 1996-12-14 1996-12-14 Recombinant baculovirus containing vp2 gene of canine parvovirus, a method for producing recombinant vp2 protein, and a vaccine containing recombinant vp2 protein

Country Status (1)

Country Link
KR (1) KR100200324B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102243371B1 (en) * 2019-04-17 2021-04-23 대한민국 Monoclonal Antibody specific for Canine Parvovirus and use thereof

Also Published As

Publication number Publication date
KR19980047324A (en) 1998-09-15

Similar Documents

Publication Publication Date Title
IL181468A (en) E2 subunit vaccine comprising recombinant pestivirus e2 protein
HUP0201783A3 (en) Anti-alfavbetha3 recombinant human antibodies, nucleic acids encoding same and methods
NZ328261A (en) 4-aryl substituted fused cycloalkanopyridines and pharmaceutical compositions containing them, intermediates
IL127872A0 (en) Analogs of cationic proteins
PT1009808E (en) Methods for generating high titer helper-free preparations of recombinant aav vectors
ZA984038B (en) Novel polyketide derivatives and recombinant methods for making same
GB2347930B (en) IGF-1 receptor interacting proteins (IIPs), genes coding therefor and uses thereof
FR14C0062I2 (en) SEQUENCES OF CIRCOVIRUS ASSOCIATED WITH PIGLE WASTING DISEASE (PAD)
EP0764010A4 (en) One-piece cervical collar
AU5002497A (en) Repositioner for head, neck, and body
ZA961849B (en) Method of purification of recombinant viral vectors containing a therapeutic gene.
AU5389898A (en) Canine parvovirus DNA vaccines
ZA972462B (en) Purification of plasmid DNA of pharmaceutical quality.
AU6967696A (en) Neck, collar bone, and spinal cord protection assembly
KR100200324B1 (en) Recombinant baculovirus containing vp2 gene of canine parvovirus, a method for producing recombinant vp2 protein, and a vaccine containing recombinant vp2 protein
AU3058897A (en) Attenuated canine parvovirus vaccine
EP1100545A4 (en) Regulated expression of recombinant proteins using rna viruses
AU1629197A (en) Expression of a foamy virus envelope protein
IL122412A0 (en) Recombinant viral nucleic acids
AU7373098A (en) Recombinant feline herpesvirus comprising a foreign dna inserted into a feline herpesvirus genome
AU3698595A (en) Dna sequence and protein of the non-structural reading frame i of the human parvovirus b19
IL114501A (en) Marek's disease virus vaccine
AU2749297A (en) Generation of viral transfectants using recombinant DNA-derived nucleoc apsid proteins
EP0732215A4 (en) Thermal print head, driving ic used therefor, and control method of thermal print head
EP1021526A4 (en) GENE DELETED RECOMBINANT FeLV PROVIRAL DNA FOR PRODUCTION OF VACCINES AGAINST FeLV

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant